These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Analysis of epitopes shared by Hirano bodies and neurofilament proteins in normal and Alzheimer's disease hippocampus. Schmidt ML; Lee VM; Trojanowski JQ Lab Invest; 1989 Apr; 60(4):513-22. PubMed ID: 2468822 [TBL] [Abstract][Full Text] [Related]
11. Direct Enhancement Effect of Hippocampal Cholinergic Neurostimulating Peptide on Cholinergic Activity in the Hippocampus. Madokoro Y; Kato D; Tsuda Y; Arakawa I; Suzuki K; Sato T; Mizuno M; Uchida Y; Ojika K; Matsukawa N Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240261 [TBL] [Abstract][Full Text] [Related]
12. Pick body-like inclusions in the dentate fascia of the hippocampus in Alzheimer's disease. Dickson DW; Yen SH; Horoupian DS Acta Neuropathol; 1986; 71(1-2):38-45. PubMed ID: 3022536 [TBL] [Abstract][Full Text] [Related]
13. Reduced Cholinergic Activity in the Hippocampus of Hippocampal Cholinergic Neurostimulating Peptide Precursor Protein Knockout Mice. Madokoro Y; Yoshino Y; Kato D; Sato T; Mizuno M; Kanamori T; Shimazawa M; Hida H; Hara H; Yoshida M; Borlongan CV; Ojika K; Matsukawa N Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661900 [TBL] [Abstract][Full Text] [Related]
14. Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques. Lee SC; Zhao ML; Hirano A; Dickson DW J Neuropathol Exp Neurol; 1999 Nov; 58(11):1163-9. PubMed ID: 10560659 [TBL] [Abstract][Full Text] [Related]
15. Caspase-cleaved actin (fractin) immunolabelling of Hirano bodies. Rossiter JP; Anderson LL; Yang F; Cole GM Neuropathol Appl Neurobiol; 2000 Aug; 26(4):342-6. PubMed ID: 10931367 [TBL] [Abstract][Full Text] [Related]
16. Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease. Maki M; Matsukawa N; Yuasa H; Otsuka Y; Yamamoto T; Akatsu H; Okamoto T; Ueda R; Ojika K J Neuropathol Exp Neurol; 2002 Feb; 61(2):176-85. PubMed ID: 11853019 [TBL] [Abstract][Full Text] [Related]
17. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Amador-Ortiz C; Lin WL; Ahmed Z; Personett D; Davies P; Duara R; Graff-Radford NR; Hutton ML; Dickson DW Ann Neurol; 2007 May; 61(5):435-45. PubMed ID: 17469117 [TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation. Arai Y; Yamazaki M; Mori O; Muramatsu H; Asano G; Katayama Y Brain Res; 2001 Jan; 888(2):287-296. PubMed ID: 11150486 [TBL] [Abstract][Full Text] [Related]
19. Directed neural lineage differentiation of adult hippocampal progenitor cells via modulation of hippocampal cholinergic neurostimulating peptide precursor expression. Sagisaka T; Matsukawa N; Toyoda T; Uematsu N; Kanamori T; Wake H; Borlongan CV; Ojika K Brain Res; 2010 Apr; 1327():107-17. PubMed ID: 20206149 [TBL] [Abstract][Full Text] [Related]
20. The cytosolic inclusion bodies that consist of splice variants that lack exon 5 of the presenilin-2 gene differ obviously from Hirano bodies observed in the brain from sporadic cases of Alzheimer's disease patients. Manabe T; Katayama T; Sato N; Kudo T; Matsuzaki S; Imaizumi K; Tohyama M Neurosci Lett; 2002 Aug; 328(2):198-200. PubMed ID: 12133587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]